TrialClinical journal of the American Society of Nephrology : CJASN2014

Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.

William E Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.